Essential thrombocytosis epidemiology and demographics: Difference between revisions
No edit summary |
No edit summary |
||
| Line 5: | Line 5: | ||
==Epidemiology== | ==Epidemiology== | ||
ET is a rare idiopathic condition affecting about 24 for every million people in the world<ref>Essential Thrombocythemia. Genetics Home Reference. http://ghr.nlm.nih.gov/condition/essential-thrombocythemia. Accessed on October 29, 2015</ref>. Although ET can present at any age, the disease usually affects middle aged to elderly individuals, with an average age at diagnosis being 50-70 years.<ref>Hoffman: Hematology: Basic Principles and Practice, 4th ed., 2005 Churchill Livingstone, Chapter 71.</ref> | |||
==References== | ==References== | ||
Revision as of 14:22, 29 October 2015
|
Essential thrombocytosis Microchapters |
|
Differentiating Essential thrombocytosis from other Diseases |
|---|
|
Diagnosis |
|
Treatment |
|
Essential thrombocytosis epidemiology and demographics On the Web |
|
American Roentgen Ray Society Images of Essential thrombocytosis epidemiology and demographics |
|
FDA on Essential thrombocytosis epidemiology and demographics |
|
CDC on Essential thrombocytosis epidemiology and demographics |
|
Essential thrombocytosis epidemiology and demographics in the news |
|
Blogs on Essential thrombocytosis epidemiology and demographics |
|
Risk calculators and risk factors for Essential thrombocytosis epidemiology and demographics |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Overview
Epidemiology
ET is a rare idiopathic condition affecting about 24 for every million people in the world[1]. Although ET can present at any age, the disease usually affects middle aged to elderly individuals, with an average age at diagnosis being 50-70 years.[2]
References
- ↑ Essential Thrombocythemia. Genetics Home Reference. http://ghr.nlm.nih.gov/condition/essential-thrombocythemia. Accessed on October 29, 2015
- ↑ Hoffman: Hematology: Basic Principles and Practice, 4th ed., 2005 Churchill Livingstone, Chapter 71.